Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

New research from the Parekh and Zaccolo groups reveals that a prototypical anchoring protein, known to be responsible for regulating several important physiological processes, also orchestrates the formation of two important universal second messengers.

Decorative comparison of rest cells and simulated cells
Proximity ligation assay reveals close interaction between AKAP79 and Orai1 Ca2+ channels, as seen by an increase in the number of small spots (in red). Red spots arise from tight co-localisation between the two proteins.

Increased biological complexity is accompanied by augmented spatial and temporal organization of biochemical processes. In many fundamental metabolic pathways, enzymes are not spatially segregated in the cytoplasm but physically interact to form functional multi-enzyme complexes in which the products of one reaction are readily accessible to the next enzyme in the cascade. Scaffolding proteins, such as members of the A kinase anchoring proteins (AKAPs) also provide a conserved and effective means for constraining enzymes and signalling molecules close to their respective targets. AKAP79 is the prototypical AKAP and regulates important physiological processes including long-term synaptic depression, insulin secretion and activation of the Ca2+-dependent transcription factor NFAT.

A collaborative study from the Parekh and Zaccolo groups have now discovered that AKAP79 orchestrates the formation of two ancient and highly conserved signal transduction pathways in the same sub-cellular region. Cytosolic Ca2+ and cyclic AMP (cAMP) are two universal second messengers which are recruited by many hormones and neurotransmitters to activate cellular effects. Both messengers elicit responses by binding to proteins; cAMP binds to and activates protein kinase A, which then phosphorylates a range of targets. Ca2+ can bind to multiple proteins including the protein phosphatase calcineurin, which dephosphorylates proteins. A major target of calcineurin is the transcription factor NFAT, which drives expression of numerous pro-inflammatory genes.

In a new paper, first authored by Dr Pulak Kar, the team demonstrate that protein kinase A, calcineurin and NFAT are bound to AKAP79 in the inner leaflet of the plasma membrane but this signalling complex relocates adjacent to a Ca2+ channel after cell stimulation. The authors also find that phosphodiesterase 4 (PDE4), an enzyme that rapidly degrades cAMP, is also part of the AKAP79 signalosome and associates with AKAP79 in a manner dependent on protein kinase A. The new results reveal that two ancient signalling pathways, Ca2+-calcineurin and cAMP-protein kinase A, are assembled close to Ca2+ channels and in a manner wholly dependent on the presence of AKAP79. These discoveries show how AKAP79 helps ensure Ca2+ and cAMP remain local signals, confined to sub-cellular regions, and further reveal new sites for interaction between these universal signalling pathways.

The full paper, "AKAP79 orchestrates a cyclic AMP signalosome adjacent to Orai1 Ca2+ channels" is available to read in Function.

Similar stories

Blood bank storage can reduce ability of transfusions to treat anaemia

New research from the Swietach Group in collaboration with NHS Blood and Transplant has demonstrated that the process of storing blood in blood banks can negatively impact the function of red blood cells and consequently may reduce the effectiveness of blood transfusions, a treatment commonly used to combat anaemia.

Feeling tired? Here’s how the brain’s ‘hourglass’ controls your need for sleep – new research

New article on The Conversation website written by Dr Lukas Krone, Associate Professor Vladyslav Vyazovskiy and Professor Zoltán Molnár.

Scientists Decipher How NeuroImmune Interactions Burn Deep Fat

A pioneering collaborative mouse study from an international team of researchers including DPAG's Associate Professor Ana Domingos published in Nature offers new therapeutic avenues for reducing visceral fat stores, which have been associated with cardiovascular disease and multiple types of cancer.

Study set to detect hidden lung damage in Long Covid Patients

Following the successful identification of long-term previously invisible lung damage in post-Covid patients, a large NIHR grant will enable a University of Oxford team including DPAG's Dr James Grist to continue this crucial work to shed light on why people with confirmed Long Covid continue to experience breathlessness following recovery from Covid-19.

Continued ethical animal research needed to advance treatment of brain disease, researchers argue

More research is needed to improve the treatment of brain diseases such as depression, Alzheimer’s or ADHD. A widely held view within the scientific community is that this cannot be done without ethically conducted animal research. A team of seventy international neuroscientists, including DPAG’s Associate Professor Vladyslav Vyazovskiy, have now published a warning that animal research is under pressure, which endangers the further development of treatments.